Literature DB >> 10597883

The role of dopamine in the nucleus accumbens in analgesia.

N Altier1, J Stewart.   

Abstract

Opioid and psychostimulant drugs have long been used for the relief of chronic pain in the clinical situation. Animal studies confirm that these drugs alleviate persistent or tonic pain. Little is known, however, about the neural systems underlying the suppression of tonic pain except that they are different from those mediating the suppression of phasic (i.e., sharp and short-lasting) pain. Although spinal and brainstem-descending pain suppression mechanisms play a role in mediating the inhibition of tonic pain, it appears that this response is additionally mediated by the activation of mechanisms lying rostral to the brainstem. Recent studies suggest that the activation of mesolimbic dopamine (DA) neurons, arising from the cell bodies of the ventral tegmental area (VTA) and projecting to the nucleus accumbens (NAcc), plays an important role in mediating the suppression of tonic pain. Other studies suggest that this pain-suppression system involving the activation of mesolimbic DA neurons is naturally triggered by exposure to stress, through the endogenous release of opioids and substance P (SP) in the midbrain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10597883     DOI: 10.1016/s0024-3205(99)00298-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  69 in total

1.  Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat.

Authors:  Thomas C Jhou; Sheng-Ping Xu; Mary R Lee; Courtney L Gallen; Satoshi Ikemoto
Journal:  Psychopharmacology (Berl)       Date:  2012-06-06       Impact factor: 4.530

2.  Smoking cessation and chronic pain: patient and pain medicine physician attitudes.

Authors:  W Michael Hooten; Kristin S Vickers; Yu Shi; Kaye L Ebnet; Cynthia O Townsend; Christi A Patten; David O Warner
Journal:  Pain Pract       Date:  2011-04-25       Impact factor: 3.183

3.  CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli.

Authors:  Michel Barrot; Jocelien D A Olivier; Linda I Perrotti; Ralph J DiLeone; Olivier Berton; Amelia J Eisch; Soren Impey; Daniel R Storm; Rachael L Neve; Jerry C Yin; Venetia Zachariou; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-06       Impact factor: 11.205

Review 4.  The biochemical bases of the placebo effect.

Authors:  Raúl de la Fuente-Fernández; A Jon Stoessl
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

5.  Rewarding electrical brain stimulation in rats after peripheral nerve injury: decreased facilitation by commonly abused prescription opioids.

Authors:  Eric E Ewan; Thomas J Martin
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

6.  Analogous responses in the nucleus accumbens and cingulate cortex to pain onset (aversion) and offset (relief) in rats and humans.

Authors:  L Becerra; E Navratilova; F Porreca; D Borsook
Journal:  J Neurophysiol       Date:  2013-06-19       Impact factor: 2.714

7.  Evidence for the modulation of nociception in mice by central mast cells.

Authors:  C L Kissel; K J Kovács; A A Larson
Journal:  Eur J Pain       Date:  2017-07-19       Impact factor: 3.931

Review 8.  Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions.

Authors:  Amanda L-C Chen; Thomas J H Chen; Roger L Waite; Jeffrey Reinking; Howard L Tung; Patrick Rhoades; B William Downs; Eric Braverman; Dasha Braverman; Mallory Kerner; Seth H Blum; Nicholas DiNubile; David Smith; Marlene Oscar-Berman; Thomas J Prihoda; John B Floyd; David O'Brien; H H Liu; Kenneth Blum
Journal:  Med Hypotheses       Date:  2008-10-31       Impact factor: 1.538

9.  Affective analgesia following muscarinic activation of the ventral tegmental area in rats.

Authors:  Robert G Kender; Steven E Harte; Elizabeth M Munn; George S Borszcz
Journal:  J Pain       Date:  2008-04-03       Impact factor: 5.820

10.  Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action.

Authors:  Kyoung-Shim Kim; Ko-Woon Lee; Kang-Woo Lee; Joo-Young Im; Ji Yeoun Yoo; Seung-Woo Kim; Ja-Kyeong Lee; Eric J Nestler; Pyung-Lim Han
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.